A growing number of lawsuits have been filed against Stryker Corporation related to its defective hips. One of the more recent Stryker Rejuvenate lawsuits involves a man from Georgia who required a revision surgery less than one-year after he developed complications following his original hip replacement. The lawsuit alleges that the defective design of the Stryker Rejuvenate product resulted in complications such as:
- Fretting and corrosion of the metal used in the device
- Toxic levels of chromium and cobalt in the blood
- Tissue damage
A unique design coming to haunt patients
A major selling point Stryker used with both surgeons and patients is that the Rejuvenate hip replacement system offers a customizable feature– which could theoretically help provide a more natural fit for each patient’s anatomy. Unlike traditional hip replacement devices using a one-piece design, the Stryker Rejuvenate is comprised of cobalt modular stem to be inserted into a femoral stem comprised of titanium. Each part of the device comes in various sizes to help assure a correct fit. The connection between the neck and stem is comprised of a unique titanium alloy which was originally touted as having superior strength and corrosion resistance compared to other alloys used in hip replacement prosthetics used by other manufacturers. Unfortunately, the wear-resistance Stryker promised proved to be little more than wishful thinking as the metal junction where the two parts of the device connect is exactly the source of problems in many people with Stryker Rejuvenate hips. A consistent stream of patient complaints of pain and premature failure resulted in a closer examination of the hip design which indeed substantiated the compaints as many recovered prosthetics demonstrated ‘fretting and corrosion’.
The recall of Stryker’s Rejuvenate & ABG II hips
In July 2012, Stryker issued a voluntary recall of all Rejuvenate and ABG II modular stems from the market citing the premature wear patterns noted above. The ‘fretting‘ and ‘corrosion‘ are not just concerning from a wear-pattern, but are also concerning as they frequently result in disabling pain and the surrounding tissue may become inflamed or even cause the tissues to die. In some patients, a condition known as a pseudo-tumor has developed in the area surrounding the hip prosthetic device. While a pseudotumor is not a cancerous ‘tumor’ it may be a pocket of swelling or adverse tissue reaction which may also contribute to pain and discomfort.
Patients with recalled Stryker hips
Depending on when and where your hip replacement was performed, you may be receiving a letter from your surgeon relating to the Stryker Rejuvenate recall. If you have not received any correspondence from your physician, you may wish to contact their office and inquire or review a copy of your operative report which will indicate the make and model of your hip prosthetic. Compared with other artifical hips, the Stryker Rejuvenate was not as popular– yet an estimated 30,000 patients may have received the recalled devices. If you are the recipient of either the Rejuvenate or ABG II device you may wish to speak to your surgeon to discuss removal or monitoring options.
Legal options available for patients with defective metal hips
Every patient who endures the challenges of a hip replacement procedure undergoes the procedure because they truly need help. For patients who have received a Stryker Rejuvenate or ABG II hip the implantation of a defective device is something that they never could have appreciated before. As we are learning now, there are some inherent design flaw with the devices which should have been corrected prior to the mass marketing of the device. If you are the recipient of a Stryker Rejuvenate or ABG II device we invite you to talk to our hip defect attorneys about your legal options to recover compensation for all aspects of your medical care and lifestyle modifications. Our lawyers are presently involved in numerous hip defect claims and have the resources and experience to help. Stryker hip recall information: http://www.fda.gov/safety/recalls/ucm311043.htm